Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Semiconductor Pedestals market size is predicted to grow from US$ 521 million in 2025 to US$ 702 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.
This studies the semiconductor pedestals, covers the metal pedestals and ceramic pedestals, used for electrostatic chucks and wafer heaters, etc.
Semiconductor manufacturing equipment is a medium tool for achieving semiconductor manufacturing processes, playing an important role in all aspects. According to SEMI, worldwide sales of semiconductor manufacturing equipment increased 5% from $102.6 billion in 2021 to an all-time record of $107.6 billion in 2022.
In recent years, the localization process of China's semiconductor industry has further accelerated, and the performance of semiconductor equipment is more flexible than the overall industry. The localization of semiconductor equipment is ushering in a golden wave, and domestic semiconductor equipment is facing more opportunities for verification and trial use, technical cooperation, and import substitution. For the third consecutive year, China remained the largest semiconductor equipment market in 2022 despite a 5% slowdown in the pace of investments in the region year over year, accounting for $28.3 billion in billings.
The record high for semiconductor manufacturing equipment sales in 2022 stems from the industry’s drive to add the fab capacity required to support long-term growth and innovations in key end markets including high-performance computing and automotive. Additionally, the results reflect investments and determination across regions to avoid future semiconductor supply chain constraints like those that surfaced during the pandemic.
LP Information, Inc. (LPI) ' newest research report, the “Semiconductor Pedestals Industry Forecast” looks at past sales and reviews total world Semiconductor Pedestals sales in 2024, providing a comprehensive analysis by region and market sector of projected Semiconductor Pedestals sales for 2025 through 2031. With Semiconductor Pedestals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Semiconductor Pedestals industry.
This Insight Report provides a comprehensive analysis of the global Semiconductor Pedestals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Semiconductor Pedestals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Semiconductor Pedestals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Semiconductor Pedestals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Semiconductor Pedestals.
This report presents a comprehensive overview, market shares, and growth opportunities of Semiconductor Pedestals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Semiconductor Pedestals market?
What factors are driving Semiconductor Pedestals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Semiconductor Pedestals market opportunities vary by end market size?
How does Semiconductor Pedestals break out by Type, by Application?
The global Semiconductor Pedestals market size is predicted to grow from US$ 521 million in 2025 to US$ 702 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.
This studies the semiconductor pedestals, covers the metal pedestals and ceramic pedestals, used for electrostatic chucks and wafer heaters, etc.
Semiconductor manufacturing equipment is a medium tool for achieving semiconductor manufacturing processes, playing an important role in all aspects. According to SEMI, worldwide sales of semiconductor manufacturing equipment increased 5% from $102.6 billion in 2021 to an all-time record of $107.6 billion in 2022.
In recent years, the localization process of China's semiconductor industry has further accelerated, and the performance of semiconductor equipment is more flexible than the overall industry. The localization of semiconductor equipment is ushering in a golden wave, and domestic semiconductor equipment is facing more opportunities for verification and trial use, technical cooperation, and import substitution. For the third consecutive year, China remained the largest semiconductor equipment market in 2022 despite a 5% slowdown in the pace of investments in the region year over year, accounting for $28.3 billion in billings.
The record high for semiconductor manufacturing equipment sales in 2022 stems from the industry’s drive to add the fab capacity required to support long-term growth and innovations in key end markets including high-performance computing and automotive. Additionally, the results reflect investments and determination across regions to avoid future semiconductor supply chain constraints like those that surfaced during the pandemic.
LP Information, Inc. (LPI) ' newest research report, the “Semiconductor Pedestals Industry Forecast” looks at past sales and reviews total world Semiconductor Pedestals sales in 2024, providing a comprehensive analysis by region and market sector of projected Semiconductor Pedestals sales for 2025 through 2031. With Semiconductor Pedestals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Semiconductor Pedestals industry.
This Insight Report provides a comprehensive analysis of the global Semiconductor Pedestals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Semiconductor Pedestals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Semiconductor Pedestals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Semiconductor Pedestals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Semiconductor Pedestals.
This report presents a comprehensive overview, market shares, and growth opportunities of Semiconductor Pedestals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Metal Pedestal
- Ceramic Pedestal
- 300mm System
- 200mm System
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Applied Materials (AMAT)
- Lam Research
- Technetics Semi
- Therm-x
- Cast Aluminum Solutions (CAS)
- Durex Industries
- Watlow (CRC)
- Backer AB
- BoBoo Hitech
- CoorsTek
- SemiXicon
- NGK Insulators (NTK Ceratec)
- Kyocera
- Shinko Electric Industries
- TOTO
- II-VI
- AK Tech Co.,Ltd
- MiCo Ceramics
- Fralock (Oasis Materials)
- Sumitomo Electric
What is the 10-year outlook for the global Semiconductor Pedestals market?
What factors are driving Semiconductor Pedestals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Semiconductor Pedestals market opportunities vary by end market size?
How does Semiconductor Pedestals break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country/Region, 2020, 2024 & 2031
2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
2.2.1 XIFAXAN
2.2.2 Viberzi
2.2.3 Lotronex
2.2.4 Other
2.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
2.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Type (2020-2025)
2.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Sales Channel
2.4.1 Hospitals Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
2.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Market Share by Sales Channel (2020-2025)
2.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Sales Channel (2020-2025)
2.5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Sales Channel (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Breakdown Data by Company
3.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2020-2025)
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2020-2025)
3.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Company
3.4 Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Location Distribution
3.4.2 Players Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
4.4 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
4.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
4.6 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
5 AMERICAS
5.1 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
5.1.1 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025)
5.1.2 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2020-2025)
5.2 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025)
5.3 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
6.1.1 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2020-2025)
6.1.2 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2020-2025)
6.2 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025)
6.3 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
7.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025)
7.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2020-2025)
7.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025)
7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
8.1.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
10.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
10.4 Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors
11.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customer
12 WORLD FORECAST REVIEW FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS BY GEOGRAPHIC REGION
12.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Region
12.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Region (2026-2031)
12.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Type (2026-2031)
12.7 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Sales Channel (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bausch Health
13.1.1 Bausch Health Company Information
13.1.2 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bausch Health Main Business Overview
13.1.5 Bausch Health Latest Developments
13.2 Allergan
13.2.1 Allergan Company Information
13.2.2 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Allergan Main Business Overview
13.2.5 Allergan Latest Developments
13.3 Sebela Pharmaceuticals
13.3.1 Sebela Pharmaceuticals Company Information
13.3.2 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sebela Pharmaceuticals Main Business Overview
13.3.5 Sebela Pharmaceuticals Latest Developments
13.4 Astellas Pharmaceuticals
13.4.1 Astellas Pharmaceuticals Company Information
13.4.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Astellas Pharmaceuticals Main Business Overview
13.4.5 Astellas Pharmaceuticals Latest Developments
13.5 Amneal Pharms
13.5.1 Amneal Pharms Company Information
13.5.2 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Amneal Pharms Main Business Overview
13.5.5 Amneal Pharms Latest Developments
13.6 Pharscin Pharma
13.6.1 Pharscin Pharma Company Information
13.6.2 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pharscin Pharma Main Business Overview
13.6.5 Pharscin Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country/Region, 2020, 2024 & 2031
2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
2.2.1 XIFAXAN
2.2.2 Viberzi
2.2.3 Lotronex
2.2.4 Other
2.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
2.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Type (2020-2025)
2.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Sales Channel
2.4.1 Hospitals Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
2.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Market Share by Sales Channel (2020-2025)
2.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Sales Channel (2020-2025)
2.5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Sales Channel (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Breakdown Data by Company
3.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2020-2025)
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2020-2025)
3.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Company
3.4 Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Location Distribution
3.4.2 Players Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
4.4 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
4.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
4.6 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
5 AMERICAS
5.1 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
5.1.1 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025)
5.1.2 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2020-2025)
5.2 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025)
5.3 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
6.1.1 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2020-2025)
6.1.2 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2020-2025)
6.2 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025)
6.3 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
7.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025)
7.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2020-2025)
7.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025)
7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
8.1.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
10.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
10.4 Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors
11.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customer
12 WORLD FORECAST REVIEW FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS BY GEOGRAPHIC REGION
12.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Region
12.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Region (2026-2031)
12.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Type (2026-2031)
12.7 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Sales Channel (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bausch Health
13.1.1 Bausch Health Company Information
13.1.2 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bausch Health Main Business Overview
13.1.5 Bausch Health Latest Developments
13.2 Allergan
13.2.1 Allergan Company Information
13.2.2 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Allergan Main Business Overview
13.2.5 Allergan Latest Developments
13.3 Sebela Pharmaceuticals
13.3.1 Sebela Pharmaceuticals Company Information
13.3.2 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sebela Pharmaceuticals Main Business Overview
13.3.5 Sebela Pharmaceuticals Latest Developments
13.4 Astellas Pharmaceuticals
13.4.1 Astellas Pharmaceuticals Company Information
13.4.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Astellas Pharmaceuticals Main Business Overview
13.4.5 Astellas Pharmaceuticals Latest Developments
13.5 Amneal Pharms
13.5.1 Amneal Pharms Company Information
13.5.2 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Amneal Pharms Main Business Overview
13.5.5 Amneal Pharms Latest Developments
13.6 Pharscin Pharma
13.6.1 Pharscin Pharma Company Information
13.6.2 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
13.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pharscin Pharma Main Business Overview
13.6.5 Pharscin Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of XIFAXAN
Table 4. Major Players of Viberzi
Table 5. Major Players of Lotronex
Table 6. Major Players of Other
Table 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025) & (K Units)
Table 8. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
Table 9. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2020-2025)
Table 11. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale by Sales Channel (2020-2025) & (K Units)
Table 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Market Share by Sales Channel (2020-2025)
Table 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Sales Channel (2020-2025) & ($ million)
Table 15. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel (2020-2025)
Table 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Sales Channel (2020-2025) & (USD/Unit)
Table 17. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2020-2025) & (K Units)
Table 18. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Producing Area Distribution and Sales Area
Table 23. Players Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
Table 24. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025) & (K Units)
Table 36. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025) & (K Units)
Table 39. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025) & (K Units)
Table 40. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2020-2025) & (K Units)
Table 41. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025) & (K Units)
Table 44. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025) & (K Units)
Table 45. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025) & (K Units)
Table 46. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025) & (K Units)
Table 48. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025) & (K Units)
Table 49. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table 54. Key Market Challenges & Risks of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table 55. Key Industry Trends of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table 56. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
Table 59. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customer List
Table 60. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Sales Channel (2026-2031) & (K Units)
Table 73. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Sales Channel (2026-2031) & ($ millions)
Table 74. Bausch Health Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 76. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bausch Health Main Business
Table 78. Bausch Health Latest Developments
Table 79. Allergan Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 81. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Allergan Main Business
Table 83. Allergan Latest Developments
Table 84. Sebela Pharmaceuticals Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 86. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Sebela Pharmaceuticals Main Business
Table 88. Sebela Pharmaceuticals Latest Developments
Table 89. Astellas Pharmaceuticals Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 91. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Astellas Pharmaceuticals Main Business
Table 93. Astellas Pharmaceuticals Latest Developments
Table 94. Amneal Pharms Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 96. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Amneal Pharms Main Business
Table 98. Amneal Pharms Latest Developments
Table 99. Pharscin Pharma Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 101. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Pharscin Pharma Main Business
Table 103. Pharscin Pharma Latest Developments
Table 1. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of XIFAXAN
Table 4. Major Players of Viberzi
Table 5. Major Players of Lotronex
Table 6. Major Players of Other
Table 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025) & (K Units)
Table 8. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
Table 9. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2020-2025)
Table 11. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale by Sales Channel (2020-2025) & (K Units)
Table 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Market Share by Sales Channel (2020-2025)
Table 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Sales Channel (2020-2025) & ($ million)
Table 15. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel (2020-2025)
Table 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Sales Channel (2020-2025) & (USD/Unit)
Table 17. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2020-2025) & (K Units)
Table 18. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Producing Area Distribution and Sales Area
Table 23. Players Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
Table 24. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025) & (K Units)
Table 36. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025) & (K Units)
Table 39. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025) & (K Units)
Table 40. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2020-2025) & (K Units)
Table 41. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025) & (K Units)
Table 44. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025) & (K Units)
Table 45. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025) & (K Units)
Table 46. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025) & (K Units)
Table 48. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025) & (K Units)
Table 49. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table 54. Key Market Challenges & Risks of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table 55. Key Industry Trends of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table 56. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
Table 59. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customer List
Table 60. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Sales Channel (2026-2031) & (K Units)
Table 73. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Sales Channel (2026-2031) & ($ millions)
Table 74. Bausch Health Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 76. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bausch Health Main Business
Table 78. Bausch Health Latest Developments
Table 79. Allergan Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 81. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Allergan Main Business
Table 83. Allergan Latest Developments
Table 84. Sebela Pharmaceuticals Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 86. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Sebela Pharmaceuticals Main Business
Table 88. Sebela Pharmaceuticals Latest Developments
Table 89. Astellas Pharmaceuticals Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 91. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Astellas Pharmaceuticals Main Business
Table 93. Astellas Pharmaceuticals Latest Developments
Table 94. Amneal Pharms Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 96. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Amneal Pharms Main Business
Table 98. Amneal Pharms Latest Developments
Table 99. Pharscin Pharma Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolios and Specifications
Table 101. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Pharscin Pharma Main Business
Table 103. Pharscin Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 2. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country/Region (2024)
Figure 10. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of XIFAXAN
Figure 12. Product Picture of Viberzi
Figure 13. Product Picture of Lotronex
Figure 14. Product Picture of Other
Figure 15. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2025
Figure 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2020-2025)
Figure 17. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Hospitals Pharmacy
Figure 18. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Hospitals Pharmacy (2020-2025) & (K Units)
Figure 19. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Retail Pharmacy
Figure 20. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Retail Pharmacy (2020-2025) & (K Units)
Figure 21. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Other
Figure 22. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Other (2020-2025) & (K Units)
Figure 23. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Market Share by Sales Channel (2024)
Figure 24. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel in 2025
Figure 25. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company in 2025 (K Units)
Figure 26. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2025
Figure 27. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company in 2025 ($ millions)
Figure 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company in 2025
Figure 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2020-2025 (K Units)
Figure 32. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2020-2025 ($ millions)
Figure 33. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2020-2025 (K Units)
Figure 34. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2020-2025 ($ millions)
Figure 35. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2020-2025 (K Units)
Figure 36. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2020-2025 ($ millions)
Figure 39. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2025
Figure 40. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2020-2025)
Figure 41. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
Figure 42. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2020-2025)
Figure 43. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region in 2025
Figure 48. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2020-2025)
Figure 49. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
Figure 50. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2020-2025)
Figure 51. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2025
Figure 59. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2020-2025)
Figure 60. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
Figure 61. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2020-2025)
Figure 62. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2020-2025)
Figure 70. Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in 2025
Figure 76. Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 77. Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 78. Channels of Distribution
Figure 79. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Forecast by Region (2026-2031)
Figure 80. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Sales Channel (2026-2031)
Figure 84. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Sales Channel (2026-2031)
Figure 1. Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 2. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country/Region (2024)
Figure 10. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of XIFAXAN
Figure 12. Product Picture of Viberzi
Figure 13. Product Picture of Lotronex
Figure 14. Product Picture of Other
Figure 15. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2025
Figure 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2020-2025)
Figure 17. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Hospitals Pharmacy
Figure 18. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Hospitals Pharmacy (2020-2025) & (K Units)
Figure 19. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Retail Pharmacy
Figure 20. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Retail Pharmacy (2020-2025) & (K Units)
Figure 21. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Other
Figure 22. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Other (2020-2025) & (K Units)
Figure 23. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Market Share by Sales Channel (2024)
Figure 24. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel in 2025
Figure 25. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company in 2025 (K Units)
Figure 26. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2025
Figure 27. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company in 2025 ($ millions)
Figure 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company in 2025
Figure 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2020-2025 (K Units)
Figure 32. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2020-2025 ($ millions)
Figure 33. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2020-2025 (K Units)
Figure 34. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2020-2025 ($ millions)
Figure 35. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2020-2025 (K Units)
Figure 36. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2020-2025 ($ millions)
Figure 39. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2025
Figure 40. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2020-2025)
Figure 41. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
Figure 42. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2020-2025)
Figure 43. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region in 2025
Figure 48. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2020-2025)
Figure 49. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
Figure 50. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2020-2025)
Figure 51. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2025
Figure 59. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2020-2025)
Figure 60. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
Figure 61. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2020-2025)
Figure 62. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2020-2025)
Figure 70. Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in 2025
Figure 76. Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 77. Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 78. Channels of Distribution
Figure 79. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Forecast by Region (2026-2031)
Figure 80. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Sales Channel (2026-2031)
Figure 84. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Sales Channel (2026-2031)
More Publications
Global Pediatric Telemedicine Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
October 2024
110 pages
Global Hydrocephalus Shunts Market Growth 2026-2032
US$ 3,660.00
January 2025
76 pages
Global Acne Vulgaris Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
92 pages
Global Gene Silencing Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
87 pages
Global Influenza Vaccine Market Growth 2025-2031
US$ 3,660.00
May 2025
125 pages
